Is Medium Chain Triglycerides Exercise Performance Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Medium Chain Triglycerides Exercise Performance Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Results ASM increased significantly in the TLN-01 group (+0.42 kg, +3.2%; p p = 0.785), with a significant between-group difference (ANCOVA p p = 0.32); within-group analysis showed a significant decline in the placebo group (-7.0%; p p = 0.537). [Chan DC (2026); evidence level 2] - Metabolomic analysis revealed reductions in plasma taurine and 1-methylhistidine and an increase in kynurenine; given the absence of clear separation on PCA/PLS-DA, these findings are considered exploratory and hypothesis-generating rather than confirmatory evidence of altered amino acid utilization or proteolysis. [Chan DC (2026); evidence level 2] - Background Sarcopenia, the age-related loss of muscle mass and strength, affects over 20% of older adults in Taiwan and contributes to frailty and functional decline. [Chan DC (2026); evidence level 2] - Nutritional supplementation offers a promising strategy for those unable to engage in structured exercise, yet multi-ingredient MCT-leucine-creatine-based interventions remain understudied in clinically defined sarcopenic populations. [Chan DC (2026); evidence level 2] - The medical and clinical applications of MCTs are diverse and include, among other things, the management of gastrointestinal disorders associated with fat malabsorption (), their use in weight management strategies (), and therapeutic approaches for neurological conditions such as epilepsy and Alzheimer's disease (). [Scheller Marc (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.